A Study to Evaluate Solriktug in Adult Participants With Asthma

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.

Key facts

Study ID
NCT06496607
Run by
Uniquity One (UNI)
People needed
145
Starts
2024-07-26
Expected to finish
2026-09-30
Last updated by the study team
2026-05-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.